
Eric Olson
Examiner (ID: 316, Phone: (571)272-9051 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1673, 1623 |
| Total Applications | 1758 |
| Issued Applications | 971 |
| Pending Applications | 175 |
| Abandoned Applications | 632 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10864144
[patent_doc_number] => 08889842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Triterpene saponins, methods of synthesis, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/613312
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 49150
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/613312 | Triterpene saponins, methods of synthesis, and uses thereof | Sep 12, 2012 | Issued |
Array
(
[id] => 8671551
[patent_doc_number] => 20130046088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-21
[patent_title] => 'Processes for the Preparation of SGLT2 Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/600985
[patent_app_country] => US
[patent_app_date] => 2012-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19309
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13600985
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/600985 | Processes for the preparation of SGLT2 inhibitors | Aug 30, 2012 | Issued |
Array
(
[id] => 9108254
[patent_doc_number] => 20130281386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'Glufosfamide Combination Therapies for Cancer'
[patent_app_type] => utility
[patent_app_number] => 13/599684
[patent_app_country] => US
[patent_app_date] => 2012-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5448
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13599684
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/599684 | Glufosfamide Combination Therapies for Cancer | Aug 29, 2012 | Abandoned |
Array
(
[id] => 8567210
[patent_doc_number] => 20120329781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-27
[patent_title] => 'COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 13/597462
[patent_app_country] => US
[patent_app_date] => 2012-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17696
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13597462
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/597462 | COMBINATIONS COMPRISING ALPHA-2-DELTA LIGANDS | Aug 28, 2012 | Abandoned |
Array
(
[id] => 9657550
[patent_doc_number] => 20140228555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-14
[patent_title] => 'PREPARATION PROCESS OF ERYTHROMYCIN THIOCYANATE'
[patent_app_type] => utility
[patent_app_number] => 14/240031
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3901
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14240031
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/240031 | Preparation process of erythromycin thiocyanate | Aug 23, 2012 | Issued |
Array
(
[id] => 8697801
[patent_doc_number] => 20130059810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING FORMS OF 5-AZACYTIDINE'
[patent_app_type] => utility
[patent_app_number] => 13/587770
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6717
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587770
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587770 | Pharmaceutical compositions comprising forms of 5-azacytidine | Aug 15, 2012 | Issued |
Array
(
[id] => 8697800
[patent_doc_number] => 20130059809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING FORMS OF 5-AZACYTIDINE'
[patent_app_type] => utility
[patent_app_number] => 13/587768
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6725
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587768
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587768 | Pharmaceutical compositions comprising forms of 5-azacytidine | Aug 15, 2012 | Issued |
Array
(
[id] => 11357366
[patent_doc_number] => 09534008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-03
[patent_title] => 'Small molecule compounds that control plant- and insect-pathogenic nematodes'
[patent_app_type] => utility
[patent_app_number] => 14/237786
[patent_app_country] => US
[patent_app_date] => 2012-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 99
[patent_figures_cnt] => 140
[patent_no_of_words] => 57712
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237786
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237786 | Small molecule compounds that control plant- and insect-pathogenic nematodes | Aug 7, 2012 | Issued |
Array
(
[id] => 9786283
[patent_doc_number] => 20140303102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Small Molecule Compounds that Control Mammal-Pathogenic Nematodes'
[patent_app_type] => utility
[patent_app_number] => 14/237800
[patent_app_country] => US
[patent_app_date] => 2012-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 97
[patent_figures_cnt] => 97
[patent_no_of_words] => 55970
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237800
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237800 | Small molecule compounds that control mammal-pathogenic nematodes | Aug 7, 2012 | Issued |
Array
(
[id] => 9786542
[patent_doc_number] => 20140303360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-09
[patent_title] => 'Small Molecule Compounds for the Control of Nematodes'
[patent_app_type] => utility
[patent_app_number] => 14/237774
[patent_app_country] => US
[patent_app_date] => 2012-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 145
[patent_figures_cnt] => 145
[patent_no_of_words] => 80642
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237774
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/237774 | Small molecule compounds for the control of nematodes | Aug 7, 2012 | Issued |
Array
(
[id] => 11311672
[patent_doc_number] => 20160347782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => '4-methylcatechol Derivatives and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 15/035276
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8441
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035276
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035276 | 4-methylcatechol Derivatives and Uses Thereof | Aug 5, 2012 | Abandoned |
Array
(
[id] => 8496461
[patent_doc_number] => 20120295869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'Sterile Hyaluronic Acid Solutions'
[patent_app_type] => utility
[patent_app_number] => 13/564161
[patent_app_country] => US
[patent_app_date] => 2012-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9060
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13564161
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/564161 | Sterile hyaluronic acid solutions | Jul 31, 2012 | Issued |
Array
(
[id] => 9596735
[patent_doc_number] => 20140193416
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-10
[patent_title] => 'OLIGOSACCHARIDES AND OLIGOSACCHARIDE-PROTEIN CONJUGATES DERIVED FROM CLOSTRIDIUM DIFFICLE POLYSACCARIDE PS-I, METHODS OF SYNTHESIS AND USES THEREOF, IN PARTICULAR AS VACCINES AND DIAGNOSTIC TOOLS'
[patent_app_type] => utility
[patent_app_number] => 14/236620
[patent_app_country] => US
[patent_app_date] => 2012-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23935
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236620
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236620 | Oligosaccharides and oligosaccharide-protein conjugates derived from Clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools | Jul 29, 2012 | Issued |
Array
(
[id] => 8496672
[patent_doc_number] => 20120296080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE'
[patent_app_type] => utility
[patent_app_number] => 13/560245
[patent_app_country] => US
[patent_app_date] => 2012-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20596
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13560245
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/560245 | GLUCOPYRANOSYL-SUBSTITUTED PHENYL DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR MANUFACTURE | Jul 26, 2012 | Abandoned |
Array
(
[id] => 8482813
[patent_doc_number] => 20120282220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-08
[patent_title] => 'GALACTOSE-PRONGED POLYSACCHARIDES IN A FORMULATION FOR ANTIFIBROTIC THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 13/550962
[patent_app_country] => US
[patent_app_date] => 2012-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8901
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13550962
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/550962 | Galactose-pronged polysaccharides in a formulation for antifibrotic therapies | Jul 16, 2012 | Issued |
Array
(
[id] => 10580865
[patent_doc_number] => 09302982
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use'
[patent_app_type] => utility
[patent_app_number] => 13/551131
[patent_app_country] => US
[patent_app_date] => 2012-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 30365
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13551131
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/551131 | Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation and use | Jul 16, 2012 | Issued |
Array
(
[id] => 8698008
[patent_doc_number] => 20130060017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-07
[patent_title] => 'METHODS FOR SYNTHESIZING LABELED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/550055
[patent_app_country] => US
[patent_app_date] => 2012-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2606
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13550055
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/550055 | METHODS FOR SYNTHESIZING LABELED COMPOUNDS | Jul 15, 2012 | Abandoned |
Array
(
[id] => 10186784
[patent_doc_number] => 09216192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-22
[patent_title] => 'Toll-like receptor agonist formulations and their use'
[patent_app_type] => utility
[patent_app_number] => 13/550192
[patent_app_country] => US
[patent_app_date] => 2012-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17790
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 99
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13550192
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/550192 | Toll-like receptor agonist formulations and their use | Jul 15, 2012 | Issued |
Array
(
[id] => 8477763
[patent_doc_number] => 20120277170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-01
[patent_title] => 'NUTRITIVE COMPOSITIONS AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/541604
[patent_app_country] => US
[patent_app_date] => 2012-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 65874
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13541604
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/541604 | NUTRITIVE COMPOSITIONS AND METHODS OF USING SAME | Jul 2, 2012 | Abandoned |
Array
(
[id] => 9491649
[patent_doc_number] => 20140142055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'METHODS OF TREATING RECURRENT MEIBOMIAN GLANDS DISORDER AND THEREBY DECREASING THE FREQUENCY OF RECURRENCE'
[patent_app_type] => utility
[patent_app_number] => 14/233152
[patent_app_country] => US
[patent_app_date] => 2012-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6143
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14233152
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/233152 | METHODS OF TREATING RECURRENT MEIBOMIAN GLANDS DISORDER AND THEREBY DECREASING THE FREQUENCY OF RECURRENCE | Jun 28, 2012 | Abandoned |